Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2017.01.020
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Elsevier BV

Related search

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Treatment of Hepatitis C With Direct-Acting Antivirals in Patients With Hepatocellular Carcinoma Before Liver Transplantation: Still an Open Issue

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Direct-Acting Antivirals-Based Therapy Decreases Hepatic Fibrosis Serum Biomarker Microfibrillar-Associated Protein 4 in Hepatitis C Patients

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2019English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy